Home / Central Data Catalog / PROJECT.REBECCA2
central

REBECCA-2
REBECCA-2

Reference ID
Project.REBECCA2
Collections
Clinical Trial
Metadata
DDI/XML JSON
Created on
Jul 07, 2026
Last modified
Jul 07, 2026
Page views
6803
Variable Groups

Variable Groups

Variable group: TumorInformation
Variables 63
agediagnosed
Age at diagnosis
chestlesions
Number of lesions in the chest
cisextent
Extent of cancer in situ
cistype
Type of CIS
ck56
CK5_6
diagnosiscomment
Diagnosis_comment
diagnosisdate
Diagnosis date.
diagnosticbasis
Diagnostic basis
distantmetastases
Is there postoperative loco-regional recurrence / distant metastases
ercomment
ER_Comment
erpercentage
ER_Percentage
erstatus
ER status immunohistochemistry
erstatus_2
ER status immunohistochemistry
firstdiscoverydate
Date of 1st discovery (Chest / chest wall)
firstdiscoverylymphnodes
Date of 1st discovery (for axillary lymph nodes)
firstmetastasisdate
Date of discovery of the 1st remote metastasis
firstmetastasislocation
Localization of the 1st remote metastasis.
firstspecvisit
Date 1st visit in specialized care
her2cis
HER2 immunohistochemistry.
her2fish
HER2_FISH
her2ihc
HER2_IHC
her2invasive
HER2
her2ishanalysiscis
HER2 ISH analysis.
her2ishanalysisinv
HER2 ISH analysis
invasivecancertype
Type of invasive cancer
invasivity
Invasivity
ki67status
Ki67 status
largestlesionsize
Size for largest lesion (mm).
lastmodified_tumor
locoregionalrecurrence
Loco-regional recurrence
lymphnodes
Total number examined lymph nodes from all axillary engagement
lymphnodesnumber
Total number of lymph nodes with metastasis (> 0.2 mm) from all axillary procedures
lympnodesoperated
Recurrence on axillary lymph nodes on the operated side
lympnodesoperatedparasterna
l
Recurrence in lymph nodes in parasternal / supraclavicular / infraclavicular region on the operated side.
mai
MAI
malignacy
Preoperatively determined malignancy
mclass
M-Classification Remote metastases
menstrualstatus
Menstrual status at diagnosis
metastasisdiagnosis
Diagnosis for metastasis
nclass
N-Classification
othercistype
Other type of CIS
otherinvasivecancer
What other invasive cancer.
patientcomment
Comment_patient
pgrcomment
PgR_Comment
pgrpercentage
PgR_Percentage
pph3
PPH3
prgstatus
PgR status immunohistochemistry
prgstatus_2
PgR status immunohistochemistry
pt
pT
recurrentside
Side for which recurrence was detected
remotemetastasis
Discovery of remote metastasis?
remotemetastasisdetection
Remote metastasis detection within three months from sampling date (diagnosis date).
removedsnls
Number of SLNs removed
screendetected
Detected in screening
side
Side
situcancerdegree
Histological degree (invasive) or nuclear type (cancer in situ)
slnmacrometastases
Number of SLNs with macrometastases (> 2mm)
slnmetastasis
Metastasis in SLN
slnmicrometastases
Number of SLNs with micrometastases
surgerymetastasisreason
Reason for no surgery or remote metastasis at diagnosis.
suspiciondate
Decision date for well-founded suspicion of cancer
tclass
T-Classification
tumorinformation_complete
Complete?
Back to Catalog